BRANDON BAILEY: Open Payments
NPI 1104181973 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 14 payments from 7 companies in 2025. Trend: 2023 $92 · 2024 $77 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $104 |
| ABBVIE INC. | 2 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Boston Scientific Corporation | 1 | $26 |
| AppliedVR Inc | 1 | $20 |
| Valinor Pharma, LLC | 1 | $20 |
| Medtronic, Inc. | 1 | $15 |
Products named: RELISTOR, Belbuca, UBRELVY, Intracept, QULIPTA, RelieVRx, MOVANTIK, SYNCHROMEDII.
Industry payments across OK — which companies pay providers there.
